Search results for "Section"

showing 10 items of 7305 documents

"Table 4" of "Measurement of W pair production in e+ e- collisions at centre-of-mass energies from 183-GeV to 209-GeV."

2004

The measured cross section for the MU NU MU NU final state. The DSYS error is the typical systematic error.

183.0-207.0E+ E- ScatteringIntegrated Cross SectionExclusiveCross SectionSIGW ProductionMuon productionE+ E- --> W+ W-E+ E- --> MU+ NUMU MU- NUMUBAR
researchProduct

"Table 13" of "Measurement of W pair production in e+ e- collisions at centre-of-mass energies from 183-GeV to 209-GeV."

2004

The total cross section for W-pair production from all decay modes combined.

183.0-207.0E+ E- ScatteringIntegrated Cross SectionExclusiveHigh Energy Physics::ExperimentCross SectionSIGW ProductionE+ E- --> W+ W-
researchProduct

"Table 3" of "Measurement of W pair production in e+ e- collisions at centre-of-mass energies from 183-GeV to 209-GeV."

2004

The measured cross section for the E NU TAU NU final state. The DSYS error is the typical systematic error.

183.0-207.0Electron productionE+ E- ScatteringE+ E- --> E- NUEBAR TAU+ NUTAUIntegrated Cross SectionExclusiveE+ E- --> E+ NUE TAU- NUTAUBARCross SectionTau productionSIGW ProductionE+ E- --> W+ W-
researchProduct

"Table 11" of "Measurement of W pair production in e+ e- collisions at centre-of-mass energies from 183-GeV to 209-GeV."

2004

The measured cross section for the final state LEPTON NU Q Q. The DSYS error is the typical systematic error.

183.0-207.0Electron productionE+ E- ScatteringHigh Energy Physics::PhenomenologyIntegrated Cross SectionE+ E- --> LEPTON- NUBAR QUARK QUARKBARExclusiveHigh Energy Physics::ExperimentE+ E- --> LEPTON+ NU QUARK QUARKBARCross SectionSIGW ProductionE+ E- --> W+ W-
researchProduct

"Table 1" of "Measurement of W pair production in e+ e- collisions at centre-of-mass energies from 183-GeV to 209-GeV."

2004

The measured cross section for the E NU E NU final state. The DSYS error is the typical systematic error.

183.0-207.0Electron productionE+ E- ScatteringIntegrated Cross SectionExclusiveCross SectionSIGW ProductionE+ E- --> W+ W-E+ E- --> E+ NUE E- NUEBAR
researchProduct

"Table 1" of "Measurement and Interpretation of Fermion-Pair Production at LEP Energies of 183 and 189 GeV"

2003

No description provided.

189.0E+ E- ScatteringIntegrated Cross SectionE+ E- --> (GAMMAS) QUARK QUARKBARExclusiveCross SectionSIG
researchProduct

"Table 8" of "Cross Sections for the Reactions e+e- --> K+ K- pi+pi-, K+ K- pi0pi0, and K+ K- K+ K- Measured Using Initial-State Radiation Events"

2013

Cross section measurements for the reaction E+ E- --> K+ K- K+ K-. Statistical errors only.

2.0125-4.4875Strange productionE+ E- ScatteringIntegrated Cross SectionExclusiveCross SectionE+ E- --> K+ K- K+ K-SIG
researchProduct

"Table 1" of "Measurement of the t anti-t production cross section in p anti-p collisions at s**(1/2) = 1.96-TeV using lepton + jets events with life…

2006

TTBAR production cross section. Error contains statistical and systematics (excluding the luminosity uncertainty).

2.0478E+062.0478E+06PBAR P --> TOP TOPBARAstrophysics::High Energy Astrophysical PhenomenaHigh Energy Physics::PhenomenologyIntegrated Cross SectionExclusiveHigh Energy Physics::ExperimentAstrophysics::Cosmology and Extragalactic AstrophysicsCross SectionSIG1960.0
researchProduct

Plasma Antithrombin Values Are Significantly Decreased in Coronavirus Disease 2019 (COVID-19) Patients with Severe Illness

2020

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Plasma AntithrombinSeverity of Illness IndexAntithrombinsCoronavirus Disease 2019medicineHumansThrombophiliaProspective StudiesPlasma Antithrombin Coronavirus Disease 2019 COVID-19business.industryHeparinSARS-CoV-2AntithrombinAnticoagulantsCOVID-19ThrombosisHematologyDisseminated Intravascular CoagulationVirologyCross-Sectional StudiesbusinessCardiology and Cardiovascular Medicinemedicine.drug
researchProduct

Attitudes of Healthcare Personnel towards Vaccinations before and during the COVID-19 Pandemic

2021

Vaccines constitute highly effective tools for controlling and eliminating vaccine-preventable diseases (VPDs) and are assessed to avert between two to three million deaths per year globally. Healthcare personnel (HCP) constitute a priority group for several vaccinations. However, studies indicate significant rates of vaccine hesitancy among them and, therefore, of acceptance of vaccination recommendations. This cross-sectional study was conducted in a university hospital in Southern Italy to assess the knowledge and attitudes of HCP about VPDs before and during the COVID-19 pandemic, estimate their intention to get vaccinated against COVID-19, and search for determinants that may influence…

2019-20 coronavirus outbreakHealth Knowledge Attitudes PracticeknowledgeCOVID-19 VaccinesCoronavirus disease 2019 (COVID-19)Cross-sectional studyOccupational riskHealth Toxicology and MutagenesisCOVID-19 Vaccinelcsh:MedicineArticle03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesEnvironmental healthHealth carePandemicoccupational riskHumansMedicineSurveys and Questionnaire030212 general & internal medicinePandemicsCross-Sectional Studie0303 health sciencesattitudes030306 microbiologybusiness.industrySARS-CoV-2lcsh:RPublic Health Environmental and Occupational HealthCOVID-19University hospitalvaccinationVaccinationCross-Sectional StudiesAttitudeItalyPandemics.vaccine hesitancybusinessHumanhealthcare personnelInternational Journal of Environmental Research and Public Health
researchProduct